Abela, L., & Kurian, M. A. (2018). Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms. Journal of Inherited Metabolic Disease, 41(6), 1077-1091.
https://doi.org/10.1007/s10545-018-0205-0
Ahmad, S. B., Ali, A., Bilal, M., Rashid, S. M., Wani, A. B., Bhat, R. R., & Rehman, M. U. (2023). Melatonin and health: insights of melatonin action, biological functions, and associated disorders. Cellular and molecular neurobiology, 43(6), 2437-2458.
Al Mughairbi, F. (2019). Mindfulness-based stress reduction: An introductory workshop. Frontiers in Human Neuroscience, 13.
https://doi.org/10.3389/conf.fnhum.2019.229.00019
Al Rubaie, T. (1994). Sexist language. Psychiatric Bulletin, 18(12), 775-775.
https://doi.org/10.1192/pb.18.12.775-a
Alushaj, E., Hemachandra, D., Kuurstra, A., Menon, R. S., Ganjavi, H., Sharma, M., . . . MacDonald, P. A. (2023). Subregional analysis of striatum iron in Parkinson’s disease and rapid eye movement sleep behaviour disorder. NeuroImage: Clinical, 40, 103519.
https://doi.org/10.1016/j.nicl.2023.103519
Anandasabapathy, N. (2012). Sensing Sun Damage. Science Translational Medicine, 4(147).
https://doi.org/10.1126/scitranslmed.3004718
Armeli, F., Bonucci, A., Maggi, E., Pinto, A., & Businaro, R. (2021). Mediterranean diet and neurodegenerative diseases: the neglected role of nutrition in the modulation of the endocannabinoid system. Biomolecules, 11(6), 790-790.
Arnaldi, D., De Carli, F., Picco, A., Ferrara, M., Accardo, J., Bossert, I., . . . Sambuceti, G. (2015). Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder? Neurobiology of Aging, 36(12), 3300-3305.
Arnulf, I., Nielsen, J., Lohmann, E., Schieffer, J., Wild, E., Jennum, P., . . . Durr, A. (2008). Rapid Eye Movement Sleep Disturbances in Huntington Disease. Archives of Neurology, 65(4), 482.
https://doi.org/10.1001/archneur.65.4.482
Bailey, G. A., Hubbard, E. K., Fasano, A., Tijssen, M. A., Lynch, T., Anderson, K. N., & Peall, K. J. (2021). Sleep disturbance in movement disorders: insights, treatments and challenges. Journal of Neurology, Neurosurgery & Psychiatry, 92(7), 723-736.
Bailey, G. A., Hubbard, E. K., Fasano, A., Tijssen, M. A. J., Lynch, T., Anderson, K. N., & Peall, K. J. (2021a). Sleep disturbance in movement disorders: insights, treatments and challenges. Journal of Neurology, Neurosurgery & Psychiatry, 92(7), 723-736.
https://doi.org/10.1136/jnnp-2020-325546
Bailey, G. A., Hubbard, E. K., Fasano, A., Tijssen, M. A. J., Lynch, T., Anderson, K. N., & Peall, K. J. (2021b). Sleep disturbance in movement disorders: insights, treatments and challenges. Journal of Neurology, Neurosurgery & Psychiatry, 92(7), 723-736
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., . . . Ceravolo, R. (2009). The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society, 24(11), 1641-1649.
Bishop, D. J., Lee, M. J. C., & Picard, M. (2025). Exercise as Mitochondrial Medicine: How Does the Exercise Prescription Affect Mitochondrial Adaptations to Training? Annual review of physiology, 87.
Bloem, B. R., Henderson, E. J., Dorsey, E. R., Okun, M. S., Okubadejo, N., Chan, P., . . . Munneke, M. (2020). Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care. The Lancet Neurology, 19(7), 623-634.
Blutstein, T., & Haydon, P. G. (2012). The Importance of astrocyte‐derived purines in the modulation of sleep. Glia, 61(2), 129-139.
https://doi.org/10.1002/glia.22422
Bohnen, N. I., & Hu, M. T. M. (2019). Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease. Journal of Parkinson’s Disease, 9(3), 603-614.
https://doi.org/10.3233/jpd-191627
Boucetta, S., Salimi, A., Dadar, M., Jones, B. E., Collins, D. L., & Dang-Vu, T. T. (2016). Structural Brain Alterations Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s Disease. Scientific Reports, 6(1).
https://doi.org/10.1038/srep26782
Breen, D. P., Vuono, R., Nawarathna, U., Fisher, K., Shneerson, J. M., Reddy, A. B., & Barker, R. A. (2014). Sleep and Circadian Rhythm Regulation in Early Parkinson Disease. JAMA Neurology, 71(5), 589.
https://doi.org/10.1001/jamaneurol.2014.65
Castro, S. L., Tapias, V., Gathagan, R., Emes, A., Brandon, T. E., & Smith, A. D. (2022). Blueberry juice augments exercise-induced neuroprotection in a Parkinson’s disease model through modulation of GDNF levels. IBRO Neuroscience Reports, 12, 217-227.
Chen, J.-F., Choi, D.-S., & Cunha, R. A. (2023). Striatopallidal adenosine A2A receptor modulation of goal-directed behavior: Homeostatic control with cognitive flexibility. Neuropharmacology, 226, 109421-109421.
Cicero, C. E., Terravecchia, C., Tabbì, S., Garofalo, R., Luca, A., Mostile, G., . . . Nicoletti, A. (2025). Exploring the relation between REM sleep behavior disorder onset and striatal dopaminergic dysfunction in Parkinson’s Disease. Journal of Neurology, 272(1), 75.
Comella, C. L., Morrissey, M., & Janko, K. (2005). Nocturnal activity with nighttime pergolide in Parkinson disease: A controlled study using actigraphy. Neurology, 64(8), 1450-1451.
https://doi.org/10.1212/01.wnl.0000158652.74601.48
Cosentino, C., & Torres, L. (2012). Propofol-induced paroxysmal dystonia. In (Vol. 18, pp. 115-116): Elsevier.
Cunha, R. A. (2008). Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. Neurochemistry International, 52(1-2), 65-72.
https://doi.org/10.1016/j.neuint.2007.06.026
Davinelli, S., Medoro, A., Savino, R., & Scapagnini, G. (2024). Sleep and oxidative stress: current perspectives on the role of NRF2. Cellular and molecular neurobiology, 44(1), 52-52.
Dodet, P., Houot, M., Leu-Semenescu, S., Corvol, J.-C., Lehéricy, S., Mangone, G., . . . Arnulf, I. (2024). Sleep disorders in Parkinson’s disease, an early and multiple problem. npj Parkinson's Disease, 10(1).
https://doi.org/10.1038/s41531-024-00642-0
Driver-Dunckley, E. D., & Adler, C. H. (2012). Movement Disorders and Sleep. Neurologic Clinics, 30(4), 1345-1358.
https://doi.org/10.1016/j.ncl.2012.08.019
Duan, W.-X., Xie, W.-Y., Ying, C., Fen, W., Cheng, X.-Y., Mao, C.-J., . . . Liu, C.-F. (2025). Butyrate improves abnormal sleep architecture in a Parkinson’s disease mouse model via BDNF/TrkB signaling. npj Parkinson's Disease, 11(1), 175-175.
Dunk, D., Mulryan, P., Affonso, S., O’Keeffe, G. W., O’Keeffe, M., & Sullivan, A. M. (2022). Diet quality, sleep and quality of life in Parkinson’s disease: a cross-sectional study. Irish Journal of Medical Science (1971 -), 192(3), 1371-1380.
https://doi.org/10.1007/s11845-022-03144-1
Dunk, D., Mulryan, P., Affonso, S., O’Keeffe, G. W., O’Keeffe, M., & Sullivan, A. M. (2023). Diet quality, sleep and quality of life in Parkinson’s disease: A cross-sectional study. Irish Journal of Medical Science (1971-), 192(3), 1371-1380.
Eban-Rothschild, A., Appelbaum, L., & de Lecea, L. (2017). Neuronal Mechanisms for Sleep/Wake Regulation and Modulatory Drive. Neuropsychopharmacology, 43(5), 937-952.
https://doi.org/10.1038/npp.2017.294
Eichenseer, S. R., Stebbins, G. T., & Comella, C. L. (2014). Beyond a motor disorder: A prospective evaluation of sleep quality in cervical dystonia. Parkinsonism & Related Disorders, 20(4), 405-408.
https://doi.org/10.1016/j.parkreldis.2014.01.004
Ernst, M., Folkerts, A.-K., Gollan, R., Lieker, E., Caro-Valenzuela, J., Adams, A., . . . Roheger, M. (2024). Physical exercise for people with Parkinson’s disease: a systematic review and network meta‐analysis. Cochrane Database of Systematic Reviews (4).
Falup‑Pecurariu, C., Diaconu, Ș., Țînț, D., & Falup‑Pecurariu, O. (2021). Neurobiology of sleep (Review). Experimental and Therapeutic Medicine, 21(3).
https://doi.org/10.3892/etm.2021.9703
Fereshtehnejad, S.-M., Yao, C., Pelletier, A., Montplaisir, J. Y., Gagnon, J.-F., & Postuma, R. B. (2019). Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study. Brain, 142(7), 2051-2067.
Fieblinger, T. (2021). Striatal Control of Movement: A Role for New Neuronal (Sub-) Populations? Frontiers in Human Neuroscience, 15.
https://doi.org/10.3389/fnhum.2021.697284
Galbiati, A., Verga, L., Giora, E., Zucconi, M., & Ferini-Strambi, L. (2019). The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. Sleep Medicine Reviews, 43, 37-46.
https://doi.org/10.1016/j.smrv.2018.09.008
García-Lorenzo, D., Longo-Dos Santos, C., Ewenczyk, C., Leu-Semenescu, S., Gallea, C., Quattrocchi, G., . . . Lehericy, S. (2013). The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease. Brain, 136(7), 2120-2129.
https://doi.org/10.1093/brain/awt152
George, N. M., & Davis, J. E. (2013). Assessing Sleep in Adolescents Through a Better Understanding of Sleep Physiology. AJN, American Journal of Nursing, 113(6), 26-31.
https://doi.org/10.1097/01.naj.0000430921.99915.24
Gittis, A. H., & Kreitzer, A. C. (2012). Striatal microcircuitry and movement disorders. Trends in Neurosciences, 35(9), 557-564.
https://doi.org/10.1016/j.tins.2012.06.008
Hyeon, J. W., Jeong, S. E., Baek, K., & Jeon, C. O. (2017). Roseitalea porphyridii gen. nov., sp. nov., isolated from a red alga, and reclassification of Hoeflea suaedae Chung et al. 2013 as Pseudohoeflea suaedae gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology, 67(2), 362-368.
Iranzo, A. (2013). A forensic sleep thriller. The Lancet Neurology, 12(7), 635. https://doi.org/10.1016/s1474-4422(13)70081-4
Iranzo, A., Valldeoriola, F., Lomeña, F., Molinuevo, J. L., Serradell, M., Salamero, M., . . . Tolosa, E. (2011). Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. The Lancet Neurology, 10(9), 797-805. https://doi.org/10.1016/s1474-4422(11)70152-1
JAMA Neurology. (2018). JAMA Neurology, 75(8), 904-904.
https://doi.org/10.1001/jamaneurol.2017.2652
JAMA Neurology. (2021). JAMA Neurology, 78(1), 3.
https://doi.org/10.1001/jamaneurol.2020.3637
Janssen Daalen, J. M., Schootemeijer, S., Richard, E., Darweesh, S. K. L., & Bloem, B. R. (2022). Lifestyle Interventions for the Prevention of Parkinson Disease. Neurology, 99(7_Supplement_1), 42-51.
https://doi.org/10.1212/wnl.0000000000200787
Kaczmarski, P., Sochal, M., Strzelecki, D., Białasiewicz, P., & Gabryelska, A. (2023). Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea. Frontiers in Neuroscience, 17.
https://doi.org/10.3389/fnins.2023.1213971
Kaushik, S., & Cuervo, A. M. (2015). Proteostasis and aging. Nature Medicine, 21(12), 1406-1415.
https://doi.org/10.1038/nm.4001
Kim, Y. E., Kim, Y. J., Hwang, H. S., & Ma, H.-i. (2020). REM sleep behavior disorder in early Parkinson’s disease predicts the rapid dopaminergic denervation. Parkinsonism & Related Disorders, 80, 120-126.
Koehler, P. J., Nonnekes, J., & Bloem, B. R. (2021). Freezing of gait before the introduction of levodopa. The Lancet Neurology, 20(2), 97. https://doi.org/10.1016/s1474-4422(19)30091-2
Langeskov-Christensen, M., Franzén, E., Grøndahl Hvid, L., & Dalgas, U. (2024). Exercise as medicine in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 95(11), 1077-1088.
https://doi.org/10.1136/jnnp-2023-332974
Langeskov-Christensen, M., Franzén, E., Hvid, L. G., & Dalgas, U. (2024). Exercise as medicine in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 95(11), 1077-1088.
Li, H., Chen, J., Xu, G., Duan, Y., Huang, D., Tang, C., & Liu, J. (2020). The effect of Tai Chi for improving sleep quality: a systematic review and meta-analysis. Journal of Affective Disorders, 274, 1102-1112.
Li, J., Xu, X., Cai, X., Weng, Y., Wang, Y., Shen, Q., & Shi, X. (2019). Oxidative medicine and cellular longevity. Hindaw: London, UK.
Li, Y., Kang, W., Yang, Q., Zhang, L., Zhang, L., Dong, F., . . . Liu, J. (2017). Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases. Neurology, 88(16), 1493-1500.
https://doi.org/10.1212/wnl.0000000000003838
Lima, M. M. S. (2013). Sleep disturbances in Parkinson's disease: The contribution of dopamine in REM sleep regulation. Sleep Medicine Reviews, 17(5), 367-375.
https://doi.org/10.1016/j.smrv.2012.10.006
Luo, W., Duan, M., Liang, E., Wang, S., & Yuan, J. (2025). The regulation of glutamatergic nervous system in sleep-wake states and general anesthesia. Brain Research Bulletin, 221, 111220.
https://doi.org/10.1016/j.brainresbull.2025.111220
Malkki, H. (2016). Exercise alleviates vascular cognitive impairment. Nature Reviews Neurology, 12(12), 679-679.
https://doi.org/10.1038/nrneurol.2016.177
Mameli, A., Marongiu, F., & Barcellona, D. (2025). Comment on article: Acquired hemophilia A as a disease of the elderly by Lehoczki A. et al. GeroScience, 47(3), 2703-2705.
https://doi.org/10.1007/s11357-025-01663-0
Marecek, S., Krajca, T., Krupicka, R., Sojka, P., Nepozitek, J., Varga, Z., . . . Zogala, D. (2024). Analysis of striatal connectivity corresponding to striosomes and matrix in de novo Parkinson’s disease and isolated REM behavior disorder. npj Parkinson's Disease, 10(1), 124.
Martinez‐Martin, P. (2020). Erratum to: “The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study”, by Ray Chaudhuri et al. (Mov Disord 2020; 35: 116‐133). Movement Disorders, 35(10), 1892-1892. https://doi.org/10.1002/mds.28266
Minakawa, E. N. (2022). Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease. Frontiers in Neurology, 13.
https://doi.org/10.3389/fneur.2022.927994
Mishina, M., Ishiwata, K., Naganawa, M., Kimura, Y., Kitamura, S., Suzuki, M., . . . Ishii, K. (2011). Adenosine A2A Receptors Measured with [11C]TMSX PET in the Striata of Parkinson's Disease Patients. PLoS ONE, 6(2), e17338.
https://doi.org/10.1371/journal.pone.0017338
Moore, R. Y. (2007). Suprachiasmatic nucleus in sleep–wake regulation. Sleep Medicine, 8, 27-33.
https://doi.org/10.1016/j.sleep.2007.10.003
Moretti, M., Neis, V. B., Matheus, F. C., Cunha, M. P., Rosa, P. B., Ribeiro, C. M., . . . Prediger, R. D. (2015). Effects of agmatine on depressive-like behavior induced by intracerebroventricular administration of 1-Methyl-4-phenylpyridinium (MPP+). Neurotoxicity research, 28(3), 222-231.
Morkovin, E., Litvinov, R., Koushner, A., & Babkov, D. (2024). Resveratrol and Extra Virgin Olive Oil: Protective Agents Against Age-Related Disease. Nutrients, 16(24), 4258-4258.
Munhoz, R. P., Moro, A., Silveira-Moriyama, L., & Teive, H. A. (2015). Non-motor signs in Parkinson’s disease: a review. Arquivos de Neuro-Psiquiatria, 73(5), 454-462.
https://doi.org/10.1590/0004-282x20150029
Naidoo, N., Ferber, M., Master, M., Zhu, Y., & Pack, A. I. (2008). Aging Impairs the Unfolded Protein Response to Sleep Deprivation and Leads to Proapoptotic Signaling. Journal of Neuroscience, 28(26), 6539-6548.
https://doi.org/10.1523/jneurosci.5685-07.2008
Naidoo, N., Giang, W., Galante, R. J., & Pack, A. I. (2005). Sleep deprivation induces the unfolded protein response in mouse cerebral cortex. Journal of Neurochemistry, 92(5), 1150-1157.
https://doi.org/10.1111/j.1471-4159.2004.02952.x
Ogrodnik, M., Karsan, S., Cirone, V., & Heisz, J. J. (2023). Correction: Ogrodnik et al. Exploring the Relationship between Cardiorespiratory Fitness and Executive Functioning in Adults with ADHD. Brain Sci. 2023, 13, 673. Brain Sciences, 13(11), 1518.
https://doi.org/10.3390/brainsci13111518
Park, J., Polidoro, P., Fortunato, C., Arnold, J., Mensh, B., Gallego, J. A., & Dudman, J. T. (2025). Conjoint specification of action by neocortex and striatum. Neuron, 113(4), 620-636.e626.
https://doi.org/10.1016/j.neuron.2024.12.024
Parker, C. T., & Garrity, G. M. (2013). Exemplar Abstract for Pseudohoeflea suaedae (Chung et al. 2013) Hyeon et al. 2017 and Hoeflea suaedae Chung et al. 2013 NamesforLife, LLC.
https://doi.org/10.1601/ex.24196
Paterno, A., Polsinelli, G., & Federico, B. (2024). Changes of brain-derived neurotrophic factor (BDNF) levels after different exercise protocols: A systematic review of clinical studies in Parkinson’s disease. Frontiers in Physiology, 15, 1352305-1352305.
Pekdemir, B., Raposo, A., Saraiva, A., Lima, M. J., Alsharari, Z. D., BinMowyna, M. N., & Karav, S. (2024). Mechanisms and potential benefits of neuroprotective agents in neurological health. Nutrients, 16(24), 4368-4368.
Petitjean, C. (2014). “Entre permission et protection... où sont la liberté et l'autonomie”? Actualités en analyse transactionnelle, N° 148(4), 56-58.
https://doi.org/10.3917/aatc.148.0056
Petzinger, G. M., Fisher, B. E., McEwen, S., Beeler, J. A., Walsh, J. P., & Jakowec, M. W. (2013). Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease. The Lancet Neurology, 12(7), 716-726.
Phillipson, O. T. (2017). Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson’s disease. An integrated strategy for management. Ageing Research Reviews, 40, 149-167.
Postuma, R. B., & Berg, D. (2016). Advances in markers of prodromal Parkinson disease. Nature Reviews Neurology, 12(11), 622-634.
https://doi.org/10.1038/nrneurol.2016.152
Raheel, K., See, Q. R., Munday, V., Fakhroo, B., Ivanenko, O., Salvatelli, M. L., . . . Naismith, S. L. (2024). Orexin and sleep disturbances in alpha-synucleinopathies: a systematic review. Current Neurology and Neuroscience Reports, 24(9), 389-412.
Romenets, S. R., Gagnon, J. F., Latreille, V., Panniset, M., Chouinard, S., Montplaisir, J., & Postuma, R. B. (2012). Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Movement Disorders, 27(8), 996-1003.
https://doi.org/10.1002/mds.25086
Ruegsegger, G. N., Pataky, M. W., Simha, S., Robinson, M. M., Klaus, K. A., & Nair, K. S. (2023). High-intensity aerobic, but not resistance or combined, exercise training improves both cardiometabolic health and skeletal muscle mitochondrial dynamics. Journal of Applied Physiology, 135(4), 763-774.
Rust, C., van den Heuvel, L. L., Bardien, S., Carr, J., Pretorius, E., Seedat, S., & Hemmings, S. M. J. (2025). Association between the relative abundance of butyrate-producing and mucin-degrading taxa and Parkinson’s disease. Neuroscience.
Salamone, J. (2010). Facing dyskinesia in Parkinson's disease: nondopaminergic approaches. Drugs of the Future, 35(7), 567.
Schröder, M., & Kaufman, R. J. (2005). ER stress and the unfolded protein response. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 569(1-2), 29-63.
https://doi.org/10.1016/j.mrfmmm.2004.06.056
Scott, A. J., Correa, L. O., Edwards, D. M., Sun, Y., Ravikumar, V., Andren, A. C., . . . Verbal, K. (2023). Metabolomic profiles of human glioma inform patient survival. Antioxidants & redox signaling, 39(13-15), 942-956.
Seixas, A., Silva, C., Bernardo-Filho, M., Taiar, R., & Caputo, D. d. C. d. S. (2025a). Editorial: Effectiveness of exercise and diet on movement disorders. Frontiers in Aging Neuroscience, 17.
https://doi.org/10.3389/fnagi.2025.1571000
Seixas, A., Silva, C., Bernardo-Filho, M., Taiar, R., & Caputo, D. d. C. d. S. (2025b). Effectiveness of exercise and diet on movement disorders. In Frontiers in Aging Neuroscience (Vol. 17, pp. 1571000-1571000): Frontiers Media SA.
Singh, R., Kiloung, J., Singh, S., & Sharma, D. (2008). Effect of paradoxical sleep deprivation on oxidative stress parameters in brain regions of adult and old rats. Biogerontology, 9(3), 153-162.
https://doi.org/10.1007/s10522-008-9124-z
Sun, J., Lai, Z., Ma, J., Gao, L., Chen, M., Chen, J., . . . Zhang, D. (2020). Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder. Movement Disorders, 35(3), 478-485.
Sun, J., Shen, A., Sun, Y., Chen, X., Li, Y., Gao, X., & Lu, B. (2024). Adaptive spatiotemporal encoding network for cognitive assessment using resting state EEG. npj Digital Medicine, 7(1), 375.
Szegezdi, E., Logue, S. E., Gorman, A. M., & Samali, A. (2006). Mediators of endoplasmic reticulum stress‐induced apoptosis. EMBO reports, 7(9), 880-885.
https://doi.org/10.1038/sj.embor.7400779
Tang, Q., Wang, S., & Zhang, K. (2020). Commentary on Barco et al. Interventions for sleep problems during pregnancy: A systematic review. Sleep Medicine Reviews, 51, 101287.
https://doi.org/10.1016/j.smrv.2020.101287
Tang, S., Huang, B., Wang, J., Zhou, L., Chau, S. W. H., Chan, J., . . . Wing, Y. K. (2023). 0912 Striatal atrophy and clinical correlates in REM sleep behavior disorder. SLEEP, 46(Supplement_1), A402-A403.
https://doi.org/10.1093/sleep/zsad077.0912
Tebbe, L., Kakakhel, M., Al-Ubaidi, M. R., & Naash, M. I. (2024). The role of syntaxins in retinal function and health. Frontiers in Cellular Neuroscience, 18.
https://doi.org/10.3389/fncel.2024.1380064
Tewari, A., Jog, R., & Jog, M. S. (2016). The Striatum and Subthalamic Nucleus as Independent and Collaborative Structures in Motor Control. Frontiers in Systems Neuroscience, 10.
https://doi.org/10.3389/fnsys.2016.00017
Thangaleela, S., Sivamaruthi, B. S., Kesika, P., Mariappan, S., Rashmi, S., Choeisoongnern, T., . . . Chaiyasut, C. (2023). Neurological Insights into Sleep Disorders in Parkinson’s Disease. Brain Sciences, 13(8), 1202.
https://doi.org/10.3390/brainsci13081202
Van Dort, C. J., Baghdoyan, H. A., & Lydic, R. (2009). Adenosine A1 and A2A receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. Journal of Neuroscience, 29(3), 871-881.
Videnovic, A., & Abbott, S. (2016). Chronic sleep disturbance and neural injury: links to neurodegenerative disease. Nature and Science of Sleep, 55.
https://doi.org/10.2147/nss.s78947
Videnovic, A., Noble, C., Reid, K. J., Peng, J., Turek, F. W., Marconi, A., . . . Zee, P. C. (2014). Circadian Melatonin Rhythm and Excessive Daytime Sleepiness in Parkinson Disease. JAMA Neurology, 71(4), 463.
https://doi.org/10.1001/jamaneurol.2013.6239
Villar-Menéndez, I., Porta, S., Buira, S. P., Pereira-Veiga, T., Díaz-Sánchez, S., Albasanz, J. L., . . . Barrachina, M. (2014). Increased striatal adenosine A2A receptor levels is an early event in Parkinson’s disease-related pathology and it is potentially regulated by miR-34b. Neurobiology of Disease, 69, 206-214.
https://doi.org/10.1016/j.nbd.2014.05.030
Wang, C., Zhou, C., Guo, T., Jiaerken, Y., Yang, S., Xu, X., . . . Zhang, M. (2023). Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson’s disease patients and healthy controls. BMC medicine, 21(1), 272-272.
Xia, Y., Li, Y., Wan, H., Hu, X., & Sun, W. (2025). Effects of different frequencies of repetitive transcranial magnetic stimulation on sleep disorders and depression in patients with Parkinson's disease: a systematic review and network meta-analysis. Frontiers in Aging Neuroscience, 17, 1623917-1623917.
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., . . . Nedergaard, M. (2013). Sleep Drives Metabolite Clearance from the Adult Brain. Science, 342(6156), 373-377.
https://doi.org/10.1126/science.1241224
Xu, Z., Anderson, K. N., & Pavese, N. (2022). Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease. Current Neurology and Neuroscience Reports, 22(10), 635-655.
https://doi.org/10.1007/s11910-022-01223-5
Yalçin, M., Grande, V., Outeiro, T. F., & Relógio, A. (2025). Circadian clock dysfunction in Parkinson’s disease: mechanisms, consequences, and therapeutic strategy. npj Parkinson's Disease, 11(1).
https://doi.org/10.1038/s41531-025-01009-9
Yang, L., Wang, F., & Strähle, U. (2020). The Genetic Programs Specifying Kolmer–Agduhr Interneurons. Frontiers in Neuroscience, 14.
https://doi.org/10.3389/fnins.2020.577879
Yuan, X.-S., Wang, L., Dong, H., Qu, W.-M., Yang, S.-R., Cherasse, Y., . . . Li, R.-X. (2017). Striatal adenosine A2A receptor neurons control active-period sleep via parvalbumin neurons in external globus pallidus. elife, 6, e29055.
Zhao, Y., Dai, Q., Li, Y., & Li, C. (2024). Exercise therapy in the application of sleep disorders. Frontiers in Neurology, 15, 1324112-1324112.
Zuzuárregui, J. R. P., & During, E. H. (2020). Sleep issues in Parkinson's disease and their management. Neurotherapeutics, 17(4), 1480-1494.